JP2023545396A5 - - Google Patents

Info

Publication number
JP2023545396A5
JP2023545396A5 JP2023520211A JP2023520211A JP2023545396A5 JP 2023545396 A5 JP2023545396 A5 JP 2023545396A5 JP 2023520211 A JP2023520211 A JP 2023520211A JP 2023520211 A JP2023520211 A JP 2023520211A JP 2023545396 A5 JP2023545396 A5 JP 2023545396A5
Authority
JP
Japan
Application number
JP2023520211A
Other languages
Japanese (ja)
Other versions
JP2023545396A (ja
JPWO2022081976A5 (https=
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2021/055186 external-priority patent/WO2022081976A1/en
Publication of JP2023545396A publication Critical patent/JP2023545396A/ja
Publication of JP2023545396A5 publication Critical patent/JP2023545396A5/ja
Publication of JPWO2022081976A5 publication Critical patent/JPWO2022081976A5/ja
Pending legal-status Critical Current

Links

JP2023520211A 2020-10-16 2021-10-15 Heliosのピペリジニル低分子分解剤および使用方法 Pending JP2023545396A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US202063092610P 2020-10-16 2020-10-16
US63/092,610 2020-10-16
US202163153599P 2021-02-25 2021-02-25
US63/153,599 2021-02-25
PCT/US2021/055186 WO2022081976A1 (en) 2020-10-16 2021-10-15 Piperidinyl small molecule degraders of helios and methods of use

Publications (3)

Publication Number Publication Date
JP2023545396A JP2023545396A (ja) 2023-10-30
JP2023545396A5 true JP2023545396A5 (https=) 2024-10-22
JPWO2022081976A5 JPWO2022081976A5 (https=) 2024-10-22

Family

ID=81208657

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023520211A Pending JP2023545396A (ja) 2020-10-16 2021-10-15 Heliosのピペリジニル低分子分解剤および使用方法

Country Status (13)

Country Link
US (1) US20240034723A1 (https=)
EP (1) EP4228651A4 (https=)
JP (1) JP2023545396A (https=)
KR (1) KR20230090318A (https=)
AU (1) AU2021361060A1 (https=)
CA (1) CA3192393A1 (https=)
CL (1) CL2023000655A1 (https=)
CR (1) CR20230143A (https=)
DO (1) DOP2023000072A (https=)
IL (1) IL301690A (https=)
MX (1) MX2023004149A (https=)
PE (1) PE20231190A1 (https=)
WO (1) WO2022081976A1 (https=)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CR20220234A (es) * 2019-10-30 2022-07-19 Dana Farber Cancer Inst Inc Degradadores de moléculas pequeñas de helios y procedimientos de uso
AU2021330835B2 (en) 2020-08-24 2023-12-14 Gilead Sciences, Inc. Phospholipid compounds and uses thereof
TW202344257A (zh) 2020-10-16 2023-11-16 美商基利科學股份有限公司 磷脂化合物及其用途
KR20240035820A (ko) 2021-07-09 2024-03-18 플렉시움 인코포레이티드 Ikzf2를 조절하는 아릴 화합물 및 약학 조성물
EP4452415B1 (en) 2021-12-22 2026-02-25 Gilead Sciences, Inc. Ikaros zinc finger family degraders and uses thereof
CN116640122A (zh) * 2022-02-16 2023-08-25 苏州国匡医药科技有限公司 Ikzf2降解剂及包含其的药物组合物和用途
KR20240161147A (ko) 2022-03-14 2024-11-12 슬랩 파마슈티컬스 엘엘씨 다중 사이클릭 화합물
CA3253296A1 (en) 2022-03-17 2023-09-21 Gilead Sciences, Inc. Zinc Finger Degradation Agents of the Ikaros Family and Their Uses
US20240327381A1 (en) * 2023-02-08 2024-10-03 Celgene Corporation Compounds and Compositions for Selective Degradation of Engineered Proteins
WO2025011624A1 (en) * 2023-07-11 2025-01-16 Etern Biopharma (Shanghai) Co., Ltd. Bifunctional compounds for androgen receptor degradation and methods of use
WO2025117881A1 (en) * 2023-12-01 2025-06-05 Casma Therapeutics, Inc. Compounds and methods for inhibiting autophagy
WO2025137640A1 (en) 2023-12-22 2025-06-26 Gilead Sciences, Inc. Azaspiro wrn inhibitors
WO2025245178A1 (en) * 2024-05-21 2025-11-27 Innovo Therapeutics, Inc. Pak4, cstf2, or cstf2t protein degraders, pharmaceutical compositions, and therapeutic applications

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI793151B (zh) * 2017-08-23 2023-02-21 瑞士商諾華公司 3-(1-氧異吲哚啉-2-基)之氫吡啶-2,6-二酮衍生物及其用途
JP7585034B2 (ja) * 2017-10-18 2024-11-18 ノバルティス アーゲー 選択的タンパク質分解のための組成物及び方法
US12227488B2 (en) * 2018-12-03 2025-02-18 Dana-Farber Cancer Institute, Inc. Small molecule degraders of Helios and methods of use
KR20210106437A (ko) * 2018-12-20 2021-08-30 노파르티스 아게 3-(1-옥소이소인돌린-2-일)피페리딘-2,6-디온 유도체를 포함하는 투약 요법 및 약학적 조합물
CN113874016A (zh) * 2019-01-29 2021-12-31 福宏治疗公司 化合物及其用途
CN113490528B (zh) * 2019-02-15 2024-12-03 诺华股份有限公司 3-(1-氧代-5-(哌啶-4-基)异吲哚啉-2-基)哌啶-2,6-二酮衍生物及其用途
CR20220234A (es) * 2019-10-30 2022-07-19 Dana Farber Cancer Inst Inc Degradadores de moléculas pequeñas de helios y procedimientos de uso
CA3161455A1 (en) * 2019-11-13 2021-05-20 Aprinoia Therapeutics Limited Compounds for degrading tau protein aggregates and uses thereof
CA3162523A1 (en) * 2019-12-23 2021-07-01 Hongfu LU Protein degradation agent compound preparation method and application
KR20220147109A (ko) * 2020-02-27 2022-11-02 노파르티스 아게 키메라 항원 수용체 발현 세포의 제조 방법

Similar Documents

Publication Publication Date Title
BR112023005462A2 (https=)
JP2023500611A5 (https=)
JP2023545396A5 (https=)
BR112023012656A2 (https=)
BR112021014123A2 (https=)
BR112023009656A2 (https=)
BR112022009896A2 (https=)
BR112021017747A2 (https=)
BR112022024743A2 (https=)
BR112022026905A2 (https=)
BR112023011738A2 (https=)
BR112023004146A2 (https=)
BR112023006729A2 (https=)
BR102021018859A2 (https=)
BR102021015500A2 (https=)
BR102021007058A2 (https=)
BR102020022030A2 (https=)
BR112023016292A2 (https=)
BR112023011610A2 (https=)
BR112023011539A2 (https=)
BR112023008976A2 (https=)
BR102021020147A2 (https=)
BR102021018926A2 (https=)
BR102021018167A2 (https=)
BR102021017576A2 (https=)